CTLA4 and B-cell chronic lymphocytic leukemia: Based on the fact that the surface CTLA-4 is of functional significance as a regulator of cell activation, we divided the patients into low and high expressors of the CTLA-4 molecule, taking as a cut-off value the median percentage of sCTLA-4-positive CLL cells (32.8 %).